Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jay Lipshitz"'
Publikováno v:
Clinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Abstract Utilization of therapeutic plasma exchange in select patients with COVID‐19 microangiopathy may provide useful treatment by modulation of inflammatory cytokines and coagulation cascade to maintain homeostasis.
Externí odkaz:
https://doaj.org/article/8aa742c5efce4d09bec0f98dc4d4f069
Autor:
Dong D. Lin, Yunhong Wu, Sudhamshi Toom, Niki Sheth, Kevin Becker, Susan Burdette-Radoux, James D'Silva, Yiwu Huang, Jay Lipshitz, Trishala Meghal, Lan Mo, Pooja Murthy, Philip Rubin, Vijaya Natarajan, Bernadine Donahue, Yiqing Xu
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Cancer patients may carry a worse prognosis with SARS-CoV-2 infection. Most of the previous studies described the outcomes of hospitalized cancer patients. We aimed to study the clinical factors differentiating patients requiring hospital
Externí odkaz:
https://doaj.org/article/5c6f4014447c4fe38bbd2b93c6891cd9
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Clinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Utilization of therapeutic plasma exchange in select patients with COVID‐19 microangiopathy may provide useful treatment by modulation of inflammatory cytokines and coagulation cascade to maintain homeostasis.
Autor:
Yiwu Huang, Kevin Becker, Jay Lipshitz, Lan Mo, Rose Snyder, Yiqing Xu, Ariel Schulman, Andrew M. Wood, Trishala Meghal
Publikováno v:
Journal of Clinical Oncology. 39:e18750-e18750
e18750 Background: The surge of the SARS coronavirus-2 (COVID-19) pandemic posed great challenges in the oncology community for optimal management of cancer patients. We sought to analyze the treatment changes experienced by the prostate cancer patie
Autor:
Sudhamshi Toom, Jasminka Balderacchi, Jason P. Shaw, David Silver, Makhardwaj Shrivastava, Prabhsimranjot Singh, Jay Lipshitz
Publikováno v:
Clinical Case Reports
Key Clinical Message Synchronous presentation of seminoma and lymphoma is rare but has important ramifications for the treatment of both malignancies. Without clinical vigilance, this situation may be easily missed, leading to inappropriate managemen
Publikováno v:
Blood Coagulation & Fibrinolysis. 23:342-344
Factor V inhibitor is in itself a rare entity. We are reporting a case of an elderly male who presented with symptoms of bleeding and was later found to have developed factor V inhibitors. He had been on amiodarone for atrial fibrillation and develop
Autor:
Jasminka Balderacchi, Sudhamshi Toom, David Silver, Jason P. Shaw, Jay Lipshitz, Makardhwaj S Shrivastava, Prabhsimranjot Singh
Publikováno v:
Blood. 128:5318-5318
Introduction: Second malignancies, including lymphoma, occur at a higher incidence in men previously treated for germ cell tumors than in the general population (1). Synchronous presentation of seminoma and lymphoma is rare but has important ramifica
Publikováno v:
Journal of gastrointestinal cancer. 44(4)
Publikováno v:
American journal of hematology. 87(3)
We read with interest Gartrell's recent report of a woman who developed a factor V inhibitor. Gartrell noted in his report that the inhibitor appeared to exhibit time dependence, as the mixing study showed slightly more prolongation of both the PT an
Publikováno v:
Acta haematologica. 124(3)